alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 33.4.2

Report on Assessment of Compliance

with Regulation AB Servicing Criteria

1. The undersigned authorized officer of LandAmerica Tax and Flood Services, Inc. (the Company) is responsible for assessing the Companys compliance
with the applicable servicing criteria as defined in 17 CFR Part 229 Section 1122(d) (4) (xi) and 1122(d) (4) (xii) (the Regulation AB Servicing Criteria) for residential and commercial mortgage backed securities
for which the Company served as third-party property tax payment provider on the underlying collateral (the Platform). Except as set forth in the preceding sentence, the servicing criteria set forth in 17 CFR Part 229
Section 1122(d) are not applicable to the activities the Company performed with respect to the Platform.

2. The Company used the criteria in 17 CFR
Part 229 Section 1122(d) to assess the compliance with the applicable Regulation AB Servicing Criteria.

3. Under one of the services offered by the
Company, some customers may elect to remit tax payments directly to tax agencies without having the Company remit those property tax payments through our tax payment service. We refer to these customers as non-outsourced servicer
customers. With respect to these non-outsourced customers and the services the Company delivered pursuant to the servicing criteria set forth in 17 CFR Part 229 Section 1122(d)(4)(xi), the Companys assertion is strictly limited to
its processing of tax payments submitted through the Companys tax payment service.

4. With respect to servicing criteria set forth in 17 CFR Part
229 Section 1122(d)(4)(xii), the Companys assertion is strictly limited to its processing of property tax penalty payments. The Company has determined that its servicer customers may also have access to systems that enable those servicers
to process penalties through obligor escrow accounts. Managements assessment of compliance does not relate to the actual or potential activities of other parties with access to obligor escrow accounts.

5. Based on such assessment, management believes that, as of and for the year ended December 31, 2007, the Company has complied in all material respects with the
Regulation AB Servicing Criteria related to the servicing of the Platform taken as a whole.

6. The registered public accounting firm of Grant Thornton,
LLP, has issued an attestation report on the Companys assessment of compliance with the Regulation AB Servicing Criteria as of and for the year ended December 31, 2007.

Date: February 6, 2008



|                                         |  |                         
|---------------------------------------- |  | ------------------------
|LandAmerica Tax and Flood Services, Inc.
|                                         | 
|By:                                      |  | /s/ Robert Ige          
|Name:                                    |  | Robert Ige              
|Its:                                     |  | Executive Vice President
**Exhibit99.2**

 

**Statement Pursuant to Section 906of the Sarbanes-Oxley Act of 2002**

**By**

**Principal Executive OfficerRegarding Facts and Circumstances Relating to Exchange Act Filings**

 

Dated – January 14, 2003

 

Inaccordance with Section 906 of the Sarbanes-Oxley Act of 2002, I, AnahitaVillafane, Controller and Chief Accounting Officer of Creative ComputerApplications, Inc. a California Corporation (“Company”), hereby certify thatthe Company’s quarterly report on Form 10-QSB for the period ended November 30,2002, fully complies with the requirements of Section 13(a) or 15(d) of theSecurities and Exchange Act of 1934, as amended, and the information containedin the quarterly report on Form 10-QSB for the period ended November 30, 2002,fairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 

INWITNESS WHEREOF, the undersigned has executed this Statement as of the datefirst written above.

 

 
|   | /s/  Anahita Villafane              |   |
|--------|------------------------------------------|--------|
|   | Anahita Villafane                        |
|   | Controller and Chief  Accounting Officer |

 

----
CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002I, Earl L Yager, as Chief Executive Officer of CHAD Therapeutics, Inc. (the “registrant”), herebycertify that:(1) I have reviewed this quarterly report on Form 10-Q of CHAD Therapeutics, Inc.; (2) Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in lightof the circumstances under which such statements were made, not misleading with respect to theperiod covered by this quarterly report; (3) Based on my knowledge, the financial statements, and other financial information included inthis quarterly report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periods presentedin this quarterly report; (4) The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: (a) designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, is madeknown to us by others within those entities, particularly during the period in which thisquarterly report is being prepared;  (b) Paragraph omitted;  (c) evaluated the effectiveness of the registrant’s disclosure controls and proceduresand presented in this report our conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered by this report based on suchevaluation; and  (d) disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting; and(5) The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing the equivalentfunctions): (a) all significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information;and  (b) any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.     Date: November 14, 2005 /s/ Earl L. Yager         Earl L. Yager    Chief Executive Officer of CHAD Therapeutics, Inc.
Case 3:17-cr-00093-WHA Document 25 Filed 02/21/17 Page 1 of 1
| (1)   | the      Annual Report on Form 10-K of Rolling Technologies, Inc. for the year      ended July 31, 2008 fully complies with the requirements of Section 13(a)      or 15(d) of the Securities Exchange Act of 1934; and |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | the      information contained in the Annual Report on Form 10-K for the year ended      July 31, 2008, fairly presents in all material respects, the financial      condition and results of operations of Rolling Technologies,      Inc. |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| By:    | /s/ Tee Kai      Shen                                              |
|--------|--------------------------------------------------------------------|
|   |                                                               |
| Name:  | Tee      Kai Shen                                                  |
|   |                                                               |
| Title: | Chief      Executive Officer, Chief Financial Officer and Director |
|   |                                                               |
| Date:  | October      14, 2008                                              |
Exhibit 31.1

CERTIFICATION

I, Martha L. Long, certify that:

1.

I have reviewed this quarterly report on Form 10-QSB of Shelter Properties V Limited Partnership;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;



4.

The small business issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:



(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b)

Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(c)

Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and



5.

The small business issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):



(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and



(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.

Date:  November 13, 2007

/s/Martha L. Long

Martha L. Long

Senior Vice President of Shelter Realty V Corporation, equivalent of the chief executive officer of the Partnership
[Federal Register Volume 86, Number 115 (Thursday, June 17, 2021)]
[Notices]
[Page 32247]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12806]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-10-2021]


Foreign-Trade Zone (FTZ) 49--Newark and Elizabeth, New Jersey; 
Authorization of Production Activity, Celgene Corporation 
(Biopharmaceuticals), Warren and Summit, New Jersey

    On February 12, 2021, Celgene Corporation submitted a notification 
of proposed production activity to the FTZ Board for its facilities 
within Subzone 49U, in Warren and Summit, New Jersey.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (86 FR 11496, February 25, 2021). On 
June 14, 2021, the applicant was notified of the FTZ Board's decision 
that no further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
Section 400.14.

    Dated: June 14, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-12806 Filed 6-16-21; 8:45 am]
BILLING CODE 3510-DS-P
June 1, 2023 

Janssen Biotech, Inc.

Attention: Ms. Ruta Walawalkar

920 Route 202

Raritan, NJ 08869

Re: Revocation of EUA 27205 - Janssen COVID-19 Vaccine

Dear Ms. Walawalkar:

This letter is in response to the request from Janssen Biotech, Inc. received on May 22, 

2023, that the U.S. Food and Drug Administration (FDA) withdraw the EUA for the 

Janssen COVID-19 Vaccine issued on February 27, 2021, as subsequently amended. 

Janssen Biotech, Inc has informed the FDA that the last lots of the Janssen COVID-19 

Vaccine purchased by the United States Government have expired, that there is no 

demand for new lots of the Janssen COVID-19 Vaccine in the United States, and that 

Janssen Biotech, Inc does not intend to update the strain composition of this vaccine to 

address emerging variants.

The authorization of a biological product for emergency use under section 564 of the 

Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. 360bbb-3) may, pursuant to 

section 564(g)(2) of the Act, be revoked when circumstances make such revocation 

appropriate to protect the public health or safety (section 564(g)(2)(C) of the Act). 

Because FDA understands that Janssen Biotech, Inc. no longer intends to offer the 

Janssen COVID-19 Vaccine in the United States under the EUA and because Janssen 

Biotech, Inc. has requested that FDA withdraw the EUA for the Janssen COVID-19 

Vaccine, FDA has determined that it is appropriate to protect the public health or safety 

to revoke this authorization.

Accordingly, FDA hereby revokes EUA 27205 for the Janssen COVID-19 Vaccine, 

pursuant to section 564(g)(2)(C) of the Act. As of the date of this letter, the Janssen 

COVID-19 Vaccine is no longer authorized for emergency use by FDA.

Notice of this revocation will be published in the Federal Register, pursuant to section 

564(h)(1) of the Act.

 

Sincerely,

Peter Marks, M.D, Ph.D.

Director

Center for Biologics Evaluation and Research
Exhibit 31.1CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002I, Earl L Yager, as Chief Executive Officer of CHAD Therapeutics, Inc. (the “registrant”), herebycertify that:(1) I have reviewed this quarterly report on Form 10-Q of CHAD Therapeutics, Inc.;(2) Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in lightof the circumstances under which such statements were made, not misleading with respect to theperiod covered by this quarterly report;(3) Based on my knowledge, the financial statements, and other financial information included inthis quarterly report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periods presentedin this quarterly report;(4) The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: (a) designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, is madeknown to us by others within those entities, particularly during the period in which thisquarterly report is being prepared;  (b) Paragraph omitted;  (c) evaluated the effectiveness of the registrant’s disclosure controls and proceduresand presented in this report our conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered by this report based on suchevaluation; and  (d) disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting; and(5) The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing the equivalentfunctions): (a) all significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information;and  (b) any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.        Date: February 8, 2007  /s/ Earl L. Yager   Earl L. Yager   Chief Executive Officer ofCHAD Therapeutics, Inc.
I 

109TH CONGRESS 

1ST SESSION H. R. 1444

To suspend temporarily the duty on certain meatless frozen food products. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 17, 2005

Mr. SHAYS introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL

To suspend temporarily the duty on certain meatless frozen 

food products.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. CERTAIN FROZEN MEATLESS PRODUCTS. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading:

‘‘ 9902.21.07 Frozen meatless preparations or frozen meat substitutes (provided for in subheading 2106.90.99) ............ Free No Change No Change On or Before 

12/31/2008 ’’. 
2

•HR 1444 IH 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to articles entered, or withdrawn 

3 from warehouse for consumption, on or after the 15th day 

4 after the date of the enactment of this Act.

Æ
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

 Respondent

 v.

RODNEY L. GREEN, JR.,

 Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 383 MAL 2014

Petition for Allowance of Appeal from the

Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 7th day of October, 2014, the Petition for Allowance of Appeal is

DENIED.
**Exhibit 32.2**

** **

**CREATIVE COMPUTER APPLICATIONS,INC.**

** **

**Certification pursuant to 18U.S.C.  Section 1350,As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

** **

In connection with the filing of the Quarterly Reporton Form 10-QSB for the period ended September 30, 2005 (the “Report”) byCreative Computer Applications, Inc. (“Registrant”), the undersigned herebycertifies that to their knowledge:

 

1.                                       TheReport fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934, as amended, and

 

2.                                       Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of Registrant as of and forthe periods presented in the Report.

 

 

Date: November 14, 2005

 

 
| /S/ Anahita Villafane                      |   |
|--------------------------------------------|--------|
| Anahita Villafane, Chief Financial Officer |

 

 

A signed original of this written statement required by Section 906 hasbeen provided to Creative Computer Applications, Inc. and will be furnished tothe Securities and Exchange Commission or its staff upon request.

 

----
1 

IN THE 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF INDIANA 

SOUTH BEND DIVISION 

FREEDOM FROM RELIGION FOUNDATION; ) 

JOHN DOE and JACK DOE; JOHN ROE; and ) 

JOHN NOE, ) 

 ) 

 Plaintiffs, ) 

 ) 

 v. ) No. 3:15-cv-463-JD-CAN 

 ) 

CONCORD COMMUNITY SCHOOLS, ) 

 ) 

 Defendant. ) 

NOTICE OF APPEARANCE 

To: The Clerk of Court and all parties of record 

 I am admitted to practice in this Court, and, having previously appeared in this case for 

plaintiffs Freedom From Religion Foundation, John Doe, and Jack Doe, I now appear in this case 

also as counsel for plaintiffs John Roe and John Noe. 

February 7, 2016 

 /s/ Gavin M. Rose 

 Gavin M. Rose, 

 ACLU OF INDIANA

 1031 E. Washington St. 

 Indianapolis, IN 46202 

 317/635-4059 

 fax: 317/635-4105 

grose@aclu-in.org 

Attorney for the plaintiffs 

USDC IN/ND case 3:15-cv-00463-JD document 46 filed 02/07/16 page 1 of 2
2 

CERTIFICATE OF SERVICE 

 I hereby certify that a true copy of the foregoing was filed electronically on this 7th day 

of February, 2016. Parties may access this document through the Court’s electronic system. The 

following persons will be served with this filing by operation of the Court’s electronic system: 

Thomas E. Wheeler, II 

<twheeler@fbtlaw.com> 

Anthony W. Overholt 

<aoverholt@fbtlaw.com> 

 /s/ Gavin M. Rose 

 Gavin M. Rose 

 Attorney at Law

USDC IN/ND case 3:15-cv-00463-JD document 46 filed 02/07/16 page 2 of 2
#### Dale J. Howard et al., Appellants, v Michael Ciorciari et al., Defendants, and William A. Ryan, Respondent.

In an automobile negligence action to recover damages for personal injuries, etc., plaintiffs appeal, as limited by their brief, from so much of an order of the Supreme Court, Dutchess County (Kelly, J.), entered October 6, 1983, as denied their cross motion for leave to enter a judgment against defendant Ryan based upon his default in appearing and directed plaintiffs’ attorneys to serve a copy of the complaint upon defendant Ryan’s attorneys within 20 days of the entry of the order.

Order affirmed, insofar as appealed from, without costs or disbursements.

On the totality of the circumstances recited and in light of CPLR 2005, 3012 (d), it was a proper exercise of discretion to relieve defendant Ryan of his default in appearing. Weinstein, J. P., Rubin, Lawrence and Kunzeman, JJ., concur.
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

ROBERT COPE a/k/a ROBERT A. COPE; ROBERT COPE, 

SUCCESSOR TRUSTEE OF BETTY J. MARKS REVOCABLE TRUST 

AGREEMENT DATED MAY 4, 2004,

Appellant,

v.

U.S. BANK N.A., AS TRUSTEE, ON BEHALF OF THE HOLDERS OF 

THE J.P. MORGAN ALTERNATIVE LOAN TRUST 2007-SI MORTGAGE 

PASS-THROUGH CERTIFICATES,

Appellee.

No. 4D22-1336

[May 18, 2023]

Appeal from the Circuit Court for the Seventeenth Judicial Circuit, 

Broward County; Andrea Gundersen, Judge; L.T. Case No. CACE18-

21891.

Michal Slavik of The Ticktin Law Group, P.A., Deerfield Beach, for 

appellant.

William L. Grimsley and Kimberly Held Israel of McGlinchey Stafford, 

Jacksonville, for appellee.

PER CURIAM.

Affirmed.

LEVINE, FORST and ARTAU, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.